Oneview Healthcare Chess Depository Interests repr 1 (ONE) AI Stock Analysis

• Market Cap: AU$232.82M
• Dividend Yield: N/A
• Average Volume (3M): 376.47K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.56
• Revenue Growth: 21.56%
• EPS Growth: -24.08%
• Country: AU
• Employees: 96
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.02
• Shares Outstanding: 767,229,900
• 10 Day Avg. Volume: 376,914
• 30 Day Avg. Volume: 376,470
• PEG Ratio: 0.00
• Price to Book (P/B): 7.20
• Price to Sales (P/S): 9.65
• P/FCF Ratio: -9.07
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.24
• Price Target Upside: -6.08% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): -0.03
• Revenue Forecast (FY): AU$23.26M

• Rating: 46 Neutral
• Price Target: AU$0.50 ▲(92.31% Upside)

The overall stock score reflects significant financial challenges, with persistent losses and negative cash flows weighing heavily. While technical indicators show bullish momentum, the overbought condition suggests caution. Valuation concerns due to a negative P/E ratio further impact the score.

Positive Factors

Revenue Growth

The company's ability to grow revenue, albeit modestly, indicates potential for market expansion and increased adoption of its digital solutions in healthcare.

Business Model

A subscription-based model provides predictable and recurring revenue streams, which can enhance financial stability and support long-term growth.

Gross Profit Margin

Improving gross profit margins suggest enhanced operational efficiency, which can lead to better profitability as the company scales its operations.

Negative Factors

Profitability Challenges

Ongoing profitability challenges indicate difficulty in achieving sustainable financial health, which could impact long-term viability and investment attractiveness.

Cash Flow Issues

Negative cash flow from operations suggests reliance on external financing, which poses risks if funding becomes less accessible, affecting financial flexibility.

Equity Position

While stockholders' equity is growing, its fragility due to ongoing net losses could undermine financial stability and limit future growth opportunities.

Oneview Healthcare Chess Depository Interests repr 1 Business Overview & Revenue Model

Company Description

Oneview Healthcare PLC develops and sells software and related consultancy services for the healthcare sector in Ireland, the United States, Australia, Asia, and the Middle East. The company operates Care Experience Platform (CXP) Cloud Start that allows customers to implement critical digital engagement capabilities across their entire enterprise; CXP Cloud Enterprise, which gives patients and their families the ability to communicate virtually with healthcare teams along with access to education and health information; and CXP Enterprise On-Prem that meets enterprise needs across various types of facilities from new construction to existing hospitals with legacy wiring. It also provides empower patients and families, manage patient experience, deliver virtual care, digital door sign, and patient communication board solutions. The company was founded in 2008 and is based in Dublin, Ireland.

How the Company Makes Money

Oneview Healthcare generates revenue through a subscription-based model, where healthcare providers pay for access to its digital platform and services. Key revenue streams include licensing fees for the software, ongoing subscription fees, and additional charges for premium features or services such as training and support. The company may also partner with healthcare institutions and technology vendors to integrate its solutions, which can lead to additional revenue opportunities through collaborative projects and shared initiatives aimed at enhancing patient care and operational efficiency.

Oneview Healthcare Chess Depository Interests repr 1 Financial Statement Overview

Summary

Oneview Healthcare shows some revenue and equity growth, but persistent losses and negative cash flows are concerning. Operational efficiency and profitability need improvement.

Income Statement

The company has struggled with profitability, evident from consistent negative EBIT and net income figures over recent years. Revenue has shown modest growth, with a 5.3% increase from 2023 to 2024, but margins remain under pressure. The Gross Profit Margin improved slightly, indicating some operational efficiency, yet the persistent net losses hinder overall performance.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio, reflecting relatively low leverage. However, the company's equity ratio has been fluctuating, indicating instability in asset financing. Although stockholders' equity has grown, it remains susceptible to ongoing net losses. The overall equity position is improving but remains fragile.

Cash Flow

Cash flow from operations is consistently negative, which, combined with capital expenditures, results in negative free cash flow. There is a reliance on financing activities to support cash flow, which could pose risks if external funding becomes less available. The ratio of operating cash flow to net income indicates that cash generation efficiency is low.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	11.57M	9.89M	9.40M	8.92M	9.73M	7.10M
Gross Profit	7.11M	6.67M	6.16M	5.35M	5.31M	4.72M
EBITDA	-12.01M	-11.26M	-7.88M	-12.09M	-8.01M	-7.44M
Net Income	-13.23M	-10.84M	-8.93M	-10.87M	-8.19M	-9.45M
Balance Sheet
Total Assets	16.15M	25.96M	21.92M	12.75M	21.09M	14.25M
Cash, Cash Equivalents and Short-Term Investments	8.19M	13.83M	11.55M	6.41M	15.18M	6.80M
Total Debt	979.00K	1.15M	935.32K	543.01K	1.20M	1.51M
Total Liabilities	8.65M	12.71M	12.78M	10.50M	11.19M	10.18M
Stockholders Equity	7.50M	13.25M	9.14M	2.26M	9.90M	4.07M
Cash Flow
Free Cash Flow	-10.11M	-10.52M	-7.79M	-10.24M	-4.09M	-7.94M
Operating Cash Flow	-10.06M	-10.47M	-7.26M	-10.20M	-4.03M	-7.69M
Investing Cash Flow	-142.66K	-459.78K	-521.38K	-44.52K	-65.26K	-249.35K
Financing Cash Flow	12.99M	13.14M	13.04M	-100.11K	12.22M	5.07M

Oneview Healthcare Chess Depository Interests repr 1 Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.26
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ONE, the sentiment is Positive. The current price of 0.26 is above the 20-day moving average (MA) of 0.26, above the 50-day MA of 0.23, and above the 200-day MA of 0.26, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 72.88 is Negative, neither overbought nor oversold. The STOCH value of 84.63 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ONE.

Oneview Healthcare Chess Depository Interests repr 1 Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CGS	73 Outperform	AU$442.79M	28.20	22.84%	0.78%	21.47%	89.09%
ALC	64 Neutral	AU$126.24M	78.33	1.89%	―	10.06%	―
PCK	55 Neutral	AU$75.17M	-8.24	-8647.54%	―	25.98%	22.10%
M7T	53 Neutral	$105.74M	―	-12.35%	―	15.99%	22.05%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
BMT	51 Neutral	AU$58.12M	-9.39	-13.83%	―	3.61%	-17.03%
ONE	46 Neutral	AU$232.82M	―	―	―	21.56%	-24.08%

Oneview Healthcare Chess Depository Interests repr 1 Corporate Events

Oneview Healthcare Appoints Michael Dowling as Non-Executive Director

Oneview Healthcare has appointed Michael J. Dowling, CEO Emeritus of Northwell Health, as a Non-Executive Director to its Board, effective December 2, 2025. Dowling’s extensive experience in healthcare innovation and leadership is expected to provide Oneview with strategic insights as it continues to expand its digital engagement platform globally. His appointment aligns with Oneview’s mission to transform patient experiences and enhance engagement through technology, promising to bolster the company’s growth and success in the healthcare industry.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare Addresses ASX Listing Rule Breach

Oneview Healthcare has identified an unintentional non-compliance with ASX Listing Rule 10.11 regarding the issuance of CHESS Depositary Interests (CDIs) to a substantial holder without necessary approvals. This oversight occurred during capital raisings and has led to a holding lock on the CDIs, pending approval from CDI holders at the upcoming AGM. Oneview is actively reviewing its compliance systems to prevent future occurrences and is seeking resolution approval to release the holding lock, which will impact the company’s operations and stakeholder relations.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare Reports Q3 2025 Financials and Operational Progress

Oneview Healthcare reported a cash balance of €5.9 million at the end of Q3 2025, with a net cash outflow of €2.2 million for the quarter. The outflow was impacted by a delayed customer renewal fee, but the company saw a subsequent cash inflow in October. Operationally, Oneview maintained strong momentum, adding a new customer, Kennedy Krieger, and progressing with deployments at existing sites. The company is on track to exceed 15,000 live endpoints by year-end and is in advanced contract discussions with potential new customers, indicating continued growth and expansion in the healthcare technology sector.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare PLC Announces Quotation of CHESS Depositary Interests

Oneview Healthcare PLC has announced the application for the quotation of 905,619 CHESS Depositary Interests on the Australian Securities Exchange. This move indicates the company’s ongoing efforts to enhance its market presence and provide liquidity options for its stakeholders, potentially impacting its operational capabilities and industry positioning positively.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare Announces Cessation of Restricted Share Units

Oneview Healthcare PLC announced the cessation of 50,000 restricted share units due to unmet conditions, reflecting a lapse in conditional rights. This development may impact the company’s capital structure and investor perception, highlighting challenges in meeting certain operational or strategic conditions.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare Announces Cessation of Securities

Oneview Healthcare PLC announced the cessation of 267,900 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for its market positioning and stakeholder interests.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare Announces Cessation of Restricted Share Units

Oneview Healthcare PLC announced the cessation of 212,723 restricted share units due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational and financial strategies.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

Oneview Healthcare PLC Announces New Quotation of Securities

Oneview Healthcare PLC has announced a new quotation of 531,000 CHESS Depositary Interests on the Australian Securities Exchange, effective September 2, 2025. This move indicates a strategic step to enhance liquidity and potentially attract more investors, reflecting the company’s ongoing efforts to strengthen its market position and expand its financial capabilities.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.